Tickerplace logo

Tickerplace

Prelude Therapeutics Incorporated logo

PRLDPrelude Therapeutics Incorporated

PRLD Stock Price, Valuation & Chart | Prelude Therapeutics Incorporated

Compare
$5.430-0.06 (-1.09%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyPRLD intrinsic valuePRLD calculated fair value vs price
OverviewFinancialsDividendsRatios

PRLD Historical price chart

PRLD Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization309.14M
PE Ratio-5.43
EPS-1.0
Trading Volume355.07K
Today's High/Low5.69/5.3
Dividend Yield0.00
52 Week High/Low6.83/0.98
Shares Outstanding78.50M
PRLD Financial Statement
PRLD Analyst ratings
PRLD Analysis & performance metrics

PRLD Company profile

Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved…

PRLD Management team

Management
Madhu Pudipeddi Ph.D.
Senior Vice President of Technical Operations
Peggy A. Scherle Ph.D.
Chief Scientific Officer
Bryant David Lim J.D.CFO
Chief Financial Officer, Chief Legal Officer & Corporate Secretary
Aimee Crombie Ph.D.
Senior Vice President and Head of Strategic Planning & Operations
Krishna Vaddi D.V.M., Ph.D.CEO
Founder, Chief Executive Officer & Director
Total 5 executives

PRLD Frequently asked questions

What is Prelude Therapeutics Incorporated (PRLD) Stock Price?

Current stock price of Prelude Therapeutics Incorporated (PRLD) stock is $5.430. The stock price is -1.09% lower in the session. The intraday range can be seen from this page. Volume of Prelude Therapeutics Incorporated (PRLD) stock is 355.07K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Prelude Therapeutics Incorporated (PRLD) stock price going up or down today?

The stock price of Prelude Therapeutics Incorporated (PRLD) can change with earnings, company news, and overall market sentiment. Prelude Therapeutics Incorporated operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Prelude Therapeutics Incorporated stock expensive at its current price?

Whether Prelude Therapeutics Incorporated looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRLD on this page is -5.43. EPS on this page is -1.00. Compare those figures with peers and growth expectations before deciding if the current Prelude Therapeutics Incorporated price is justified.

How has the stock price of Prelude Therapeutics Incorporated (PRLD) performed historically?

Historical performance for Prelude Therapeutics Incorporated (PRLD) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRLD reacted to past earnings and market events.

Should I buy Prelude Therapeutics Incorporated (PRLD) stock, at this price?

Buying Prelude Therapeutics Incorporated (PRLD) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.